CAS 133099-07-7
:Darifenacin hydrobromide
Description:
Darifenacin hydrobromide is a medication primarily used to treat overactive bladder symptoms, such as urgency, frequency, and incontinence. It functions as a selective antagonist of the muscarinic acetylcholine receptors, particularly the M3 subtype, which are involved in bladder contraction. This selectivity helps minimize side effects commonly associated with anticholinergic drugs. The substance appears as a white to off-white crystalline powder and is soluble in water and methanol, which facilitates its formulation in various dosage forms. Darifenacin hydrobromide is typically administered orally and has a relatively long half-life, allowing for once-daily dosing. Common side effects may include dry mouth, constipation, and blurred vision, reflecting its anticholinergic activity. As with any medication, it is essential to consider contraindications and potential interactions with other drugs. Overall, darifenacin hydrobromide represents a targeted approach to managing bladder dysfunction, improving the quality of life for individuals affected by this condition.
Formula:C28H29BrN2O2
InChI:InChI=1/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H
InChI key:InChIKey=UQAVIASOPREUIT-VQIWEWKSSA-N
SMILES:C(C(N)=O)([C@H]1CN(CCC=2C=C3C(=CC2)OCC3)CC1)(C4=CC=CC=C4)C5=CC=CC=C5.Br
Synonyms:- (S)-3-(Carbamoyldiphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine hydrobromide
- 2-[(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide
- 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1)
- 2-{1-[2-(2,3-Dihydro-1-Benzofuran-5-Yl)Ethyl]Pyrrolidin-3-Yl}-2,2-Diphenylacetamide Hydrobromide (1:1)
- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, hydrobromide (1:1), (3S)-
- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, monohydrobromide, (3S)-
- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, monohydrobromide, (S)-
- Darifenacin HBr
- Darilong
- Emselex
- Enablex
- UK 88525-04 hydrobromide
- Uk 88525-04
- {1-[2-(2,3-Dihydrobenzofuran-5-Yl)Ethyl]-3-Pyrrolidnyl}-2,2-Diphenylacetamide Hydrobromide
- Darifenacin hydrobromide
- DARIFENACIN HYDROBROMIDE 99.0%
- Emsele
- Darifenacin Hydrobromid
- Darifenacin hydrobromide (Under R&D)
- (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-a-a-diphenyl-3-pyrrolidineacetamide Hydrobromide
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
Darifenacin Hydrobromide
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C28H30N2O2·HBrColor and Shape:White PowderMolecular weight:506.156893-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, hydrobromide (1:1), (3S)-
CAS:Formula:C28H31BrN2O2Purity:98%Color and Shape:SolidMolecular weight:507.4619Darifenacin hydrobromide
CAS:<p>Darifenacin hydrobromide (UK-88525) is a selective muscarinic receptor antagonist used to treat urinary incontinence and overactive bladder syndrome.</p>Formula:C28H31BrN2O2Purity:99.75% - >99.99%Color and Shape:SolidMolecular weight:505.45Darifenacin HBr
CAS:Formula:C28H30N2O2·HBrColor and Shape:White To Off-White SolidMolecular weight:426.56 80.91Darifenacin Hydrobromide
CAS:Controlled ProductFormula:C28H30N2O2·BrHColor and Shape:NeatMolecular weight:507.46Darifenacin HBr - Bio-X ™
CAS:Controlled Product<p>Darifenacin is a muscarinic antagonist that is used for the treatment of urinary incontinence. It specifically blocks the M3 muscarinic acetylcholine receptor which in return reduces the urgency to urinate.</p>Formula:C28H30N2O2·HBrPurity:Min. 95%Color and Shape:PowderMolecular weight:507.46 g/molDarifenacin HBr
CAS:Controlled Product<p>Muscarinic (M3) ACh receptor antagonist</p>Formula:C28H30N2O2·HBrPurity:Min. 95%Color and Shape:PowderMolecular weight:507.46 g/mol








